Join
Live feed
·
INSIDERFilingvia Quantisnow
CAMP4 Therapeutics Corporation logo

Chief Scientific Officer Tardiff Daniel sold $8,273 worth of shares (1,738 units at $4.76), closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CAMP· CAMP4 Therapeutics Corporation
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CAMP (CAMP4 Therapeutics Corporation) and more on Quantisnow.